Slayton RE - Search Results

1

A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments.

Taylor SG 4th, DeWys WD, Perlia CP, Wolter J, Slayton RE, Kosova LA, Khandekar JD. Taylor SG 4th, et al. Among authors: slayton re. Cancer. 1979 Sep;44(3):824-30. doi: 10.1002/1097-0142(197909)44:3<824::aid-cncr2820440306>3.0.co;2-n. Cancer. 1979. PMID: 383272 Clinical Trial.

2

Chemotherapy for advanced germinal cell neoplasms: preliminary report of an Eastern Cooperative Oncology Group Study.

DeWys WD, Begg C, Slayton R, Hahn RG, Brodsky I. DeWys WD, et al. Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1675-80. Cancer Treat Rep. 1979. PMID: 91437 Clinical Trial.

3

Clinical study with bleomycin.

Shastri S, Slayton RE, Wolter J, Perlia CP, Taylor SG 3rd. Shastri S, et al. Among authors: slayton re. Cancer. 1971 Nov;28(5):1142-6. doi: 10.1002/1097-0142(1971)28:5<1142::aid-cncr2820280509>3.0.co;2-a. Cancer. 1971. PMID: 4108197 No abstract available.

4

Preliminary clinical experience with cis-diamminedichloroplatinum (II) (NSC 119875, CACP).

Rossof AH, Slayton RE, Perlia CP. Rossof AH, et al. Among authors: slayton re. Cancer. 1972 Dec;30(6):1451-6. doi: 10.1002/1097-0142(197212)30:6<1451::aid-cncr2820300606>3.0.co;2-q. Cancer. 1972. PMID: 4641756 No abstract available.

5

Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas.

Bonomi PD, Slayton RE, Wolter J. Bonomi PD, et al. Among authors: slayton re. Cancer Treat Rep. 1978 Aug;62(8):1211-3. Cancer Treat Rep. 1978. PMID: 356979 Clinical Trial. No abstract available.

6

Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract.

Khandekar JD, Elson PJ, DeWys WD, Slayton RE, Harris DT. Khandekar JD, et al. Among authors: slayton re. J Clin Oncol. 1985 Apr;3(4):539-45. doi: 10.1200/JCO.1985.3.4.539. J Clin Oncol. 1985. PMID: 3884746 Clinical Trial.

7

Vindesine: phase II evaluation in colon cancer and description of its platelet stimulating activity.

Pazdur R, Rossof AH, Chandra G, Bonomi PD, Slayton RE, Wolter J. Pazdur R, et al. Among authors: slayton re. Cancer Chemother Pharmacol. 1982;9(1):41-4. doi: 10.1007/BF00296760. Cancer Chemother Pharmacol. 1982. PMID: 7139851

8

New approach to the treatment of hypercalcemia. The effect of short-term treatment with mithramycin.

Slayton RE, Shnider BI, Elias E, Horton J, Perlia CP. Slayton RE, et al. Clin Pharmacol Ther. 1971 Sep-Oct;12(5):833-7. doi: 10.1002/cpt1971125833. Clin Pharmacol Ther. 1971. PMID: 4936148 Clinical Trial. No abstract available.

9

Management of carcinoid syndrome.

Bonomi P, Hovey C, Dainauskas JR, Slayton R, Wolter J. Bonomi P, et al. Med Pediatr Oncol. 1979;6(1):77-83. doi: 10.1002/mpo.2950060111. Med Pediatr Oncol. 1979. PMID: 440207

10

Letter: Mithramycin for hypercalcemia.

Slayton RE, Perlia C, Showel J, Hoeltgen T, Wolter J. Slayton RE, et al. Ann Intern Med. 1975 Aug;83(2):288. doi: 10.7326/0003-4819-83-2-288_1. Ann Intern Med. 1975. PMID: 125059 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters